BERGSTEIN IVAN (Chief Executive Officer) sold 2.1% of their position (56.32K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $849.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/28/2019ACC: 0001104659-19-038309
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-56.32K
Net shares
Net seller
$849.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
56.32K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−10.82K
Price / share
$15.49
Trade value
$167.63K
% of position
0.4%
6/24/2019
2.66M→2.65M
Common Stock
Direct
Shares
−28.50K
Price / share
$15.10
Trade value
$430.35K
% of position
1.1%
6/25/2019
2.65M→2.62M
Common Stock
Direct
Shares
−16.99K
Price / share
$14.77
Trade value
$251K
% of position
0.6%
6/26/2019
2.62M→2.61M
Total
Net shares
−56.32K
Net value
-$848.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/24/2019 | S · Sale | −10.82K | $15.49 | $167.63K | 0.4% | 2.66M | 2.65M |
| Common Stock Direct | 6/25/2019 | S · Sale | −28.50K | $15.10 | $430.35K | 1.1% | 2.65M | 2.62M |
| Common Stock Direct | 6/26/2019 | S · Sale | −16.99K | $14.77 | $251K | 0.6% | 2.62M | 2.61M |
| Total | −56.32K | -$848.98K | ||||||
Derivative Transactions0
No derivative transactions reported